ESMO AIA

Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of tissue specimens, and the role of advocates in shaping public policy [...]

Selma Schimmel (Vital Options International), Kathy Redmond (Editor, Cancer World Magazine), Jola Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the media and cancer reporting. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy In Action®, bringing together the influential leaders of the [...]

Selma Schimmel (Vital Options International), Kathy Oliver (International Brain Tumor Alliance), Francesco De Lorenzo (European Cancer Patient Coalition), Jola Gore Booth (EuropaColon) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss tissue collection in cancer research. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy In Action®, [...]

Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy), Selma Schimmel (Vital Options International) and Stefania Vallone (Women Against Lung Cancer Europe – WALCE) discuss pathology and personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders [...]

Kathy Oliver (International Brain Tumor Alliance), Angelo Paolo Dei Tos, MD (Molecular Pathologist, General Hospital in Treviso, Italy) and Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) discuss the challenges of the genetic marker testing requirements for patients. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in [...]

Ian Banks (Chair of the ECCO Patient Advisory Committee) talks about the futire of personalized cancer medicine in Europe. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its [...]

Francesco De Lorenzo (European Cancer Patient Coalition) talks about the key policy issues around personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, [...]

Lorenz Jost (Chair, ESMO Patient Working Group) talks about personalized medicine and the importance of educating patients on the topic. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, [...]

Fortunato Ciardiello (Chair, ESMO Personalized Medicine Working Group) introduces personalized medicine. Vital Options International and the European Society for Medical Oncology (ESMO) presents the 3rd Patient Advocacy in Action®, bringing together the influential leaders of the cancer advocacy community to address Personalized Medicine: What it means, its relevance for patients, future research perspectives, collection of [...]

Vital Options presents Advocacy in Action (AIA), in partnership with the ESMO Cancer Patient Working Group and in collaboration with the ECCO Patient Advisory Committee. This six-part AIA Forum brings together influential leaders in cancer advocacy, to address the core issues that impact cancer survivorship. Joining Vital Options CEO, Selma Schimmel, will be AIA co-chair [...]